Differential normalization of mucosal interleukin-8 and interleukin-6 activity after Helicobacter pylori eradication

Infection and Immunity

Volumn 66, Issue 10, 1998, Pages 4742-4747

  Ando, Takafumi ^a   Kusugami, Kazuo ^a   Ohsuga, Masahiro ^a   Ina, Kenji ^a   Shinoda, Masataka ^a   Konagaya, Toshihiro ^a   Sakai, Tetsu ^a   Imada, Akira ^a   Kasuga, Naomi ^a   Nada, Toshi ^a   Ichiyama, Satoshi ^a   Blaser, Martin J ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; INTERLEUKIN 6; INTERLEUKIN 8; METRONIDAZOLE; OMEPRAZOLE;

ARTICLE; BACTERICIDAL ACTIVITY; DUODENUM ULCER; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH MUCOSA; TREATMENT OUTCOME;

EID: 0031705619     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.10.4742-4747.1998     Document Type: Article

References (37)

1. Alam, K., T. T. Schubert, S. D. Bologna, and C. K. Ma. 1992. Increased density of Helicobacter pylori on antral biopsy is associated with severity of acute and chronic inflammation and likelihood of duodenal ulceration. Am. J. Gastroenterol. 87:424-448.
2. Ando, T., K. Kusugami, M. Ohsuga, M. Shinoda, M. Sakakibara, H. Saito, A. Fukatsu, S. Ichiyama, and M. Ohta. 1996. Interleukin-8 activity correlates with histological severity in Helicobacter pylori-associated antral gastritis. Am. J. Gastroenterol. 91:1150-1156.
3. Blaser, M. J. 1992. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 102:720-727.
4. Borody, T., P. Andrews, N. Mancuso, E. Jankiewicz, and S. Brandl. 1992. Helicobacter pylori reinfection 4 years post-eradication. Lancet 339:1295.
5. Coghlan, J, G., D. Gilligan, H. Humphreys, D. McKenna, C. Dooley, E. Sweeney, C. Keane, and C. O'Morain. 1987. Campylobacter pylori and recurrence of duodenal ulcers. Lancet ii:1109-1111.
6. Crabtree, J. E., P. Peichl, J. I. Wyatt, U. Stachl, and I. J. D. Lindley. 1993. Gastric interleukin-8 and IgA IL-8 autoantibodies in Helicobacter pylori infection. Scand. J. Immunol. 37:65-70.
7. Crabtree, J. E., J. I. Wyatt, L. K. Trejdosiewics, P. Peichl, P. H. Nichols, N. Ramsay, J. N. Primrose, and I. J. Lindley. 1994. lnterleukin-8 expression in Helicobacter pylori-infected, normal, and neoplastic gastroduodenal mucosa. J. Clin. Pathol. 47:61-66.
8. Crabtree, J. E. 1996. Gastric mucosal inflammatory responses to Helicobacter pylori. Aliment. Pharmacol. Ther. 10:24-37.
9. Crowe, S. E., L. Alvarez, M. Dytoc, R. H. Hunt, M. Muller, P. Sherman, J. Patel, Y. Jin, and P. B. Ernst. 1995. Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro. Gastroenterology 108:65-74.
10. Dixon, M. F. 1991. Helicobacter pylori and peptic ulceration. J. Gastroenterol. Hepatol. 6:125-130.
11. Gionchetti, P., D. Vaira, M. Campieri, J. Holton, M. Menegatti, A. Belluzzi, E. Bertinelli, M. Ferretti, C. Brignola, M. Miglioli, and L. Barbara. 1994. Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients. Am. J. Gastroenterol. 89:883-887.
12. Harris, P. R., H. L. T. Mobley, G. I. Perez-Perez, M. J. Blaser, and P. D. Smith. 1996. Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production. Gastroenterology 111:419-425.
13. Hentschel, E., G. Brandstatter, B. Dragosics, A. M. Hirschl, H. Nemec, K. Schutze, M. Taufer, and H. Wurzer. 1993. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N. Engl. J. Med. 328:308-312.
14. Hirano, T., T. Matsuda, M. Turner, N. Miyasaka, G. Buchan, B. Tang, K. Sato, M. Shimizu, R. Maini, M. Feldmann, and T. Kishimoto. 1988. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur. J. Immunol. 18:1797-1801.
15. Ho, Y. C., N. Mukaida, S. Ishiyama, A. Tokue, T. Kawai, K. Matsushima, and T. Kasahara. 1993. Elevated interleukin-8 levels in the urine of patients with urinary tract infections. Infect. Immun. 61:1307-1314.
16. Horii, Y., A. Muraguchi, M. Iwano, T. Matsuda, T. Hirayama, H. Yamada, Y. Fuji, K. Dohi, H. Ishikawa, Y. Ohmoto, K. Yoshizaki, T. Hirano, and T. Kishimoto. 1989. Involvement of IL-6 in mesangial proliferate glomerulonephritis. J. Immunol. 143:3949-3955.
17. Kirschner, D. E., and M. J. Blaser. 1995. The dynamics of Helicobacter pylori infection of the human stomach. J. Theor. Biol. 176:281-290.
18. Kishimoto, T. 1989. The biology of interleukin-6. Blood 74:1-10.
19. Kusugami, K., A. Fukatsu, M. Tanimoto, M. Shinoda, J. Haruta, A. Kuroiwa, K. Ina, K. Kanayama, T. Ando, T. Matsuura, T. Yamaguchi, K. Morise, M. Ieda, H. Iokawa, A. Ishihara, and S. Sarai. 1995. Elevation of interleukin-6 in inflammatory bowel disease is macrophage- and epithelial cell-dependent. Dig. Dis. Sci. 40:949-959.
20. Linker-Israeli, M., R. J. Deans, D. J. Wallace, J. Prehn, T. Ozeri-Chen, and J. R. Klinenberg. 1991. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J. Immunol. 147:117-123.
21. Mahida, Y. R., M. Ceska, F. Effenberger, L. Kurlak, I. Lindley, and J. Hawkey. 1992. Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative colitis. Gin. Sci. 82:273-275.
22. Marshall, B. J., and J. R. Warren. 1984. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet i:1311-1314.
23. Marshall, B. J., J. R. Warren, E. D. Blincow, M. Phillips, C. S. Goodwin, R. Murray, S. J. Blackbourn, T. E. Waters, and C. R. Sanderson. 1988. Prospective double blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet ii:1437-1442.
24. Morgan, D., W. Kraft, M. Bender, and A. Pearson, 1988. Nitrofurans in the treatment of gastritis associated with Campylobacter pylori. Gastroenterology 95:1178-1184.
25. Moss, S. F., S. Legon, J. Davies, and J. Calam. 1994. Cytokine gene expression in Helicobacter pylori associated antral gastritis. Gut 35:1567-1570.
26. Noach, L. A., N. B. Bosma, J. Jansen, F. J. Hoek, S. J. H. van Deventer, and G. N. J. Tytgat. 1994. Mucosal tumor necrosis factor-α, interleukin-1β, and interleukin-8 production in patients with Helicobacter pylori infection. Scand. J. Gastroenterol. 29:425-429.
27. Peterson, G. L. 1977. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83:346-356.
28. Price, A. B. 1991. The Sydney system: histological division. J. Gastroenterol. Hepatol. 6:209-222.
29. Rauws, E. A., W. Langenberg, H. J. Houthoff, H. C. Zanen, and G. N. J. Tytgat. 1988. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 94:33-40.
30. Satoh, K., K. Kimura, Y. Yoshida, T. Kasano, K, Kihira, and Y. Taniguchi. 1991. A topographical relationship between Helicobacter pylori and gastritis: quantitative assessment of Helicobacter pylori in the gastric mucosa. Am. J. Gastroenterol. 86:285-291.
31. Seitz, M., B. Dewald, N. Gerber, and M. Baggiolini. 1991. Enhanced production of neutrophil-activating peptide-l/interleukin-8 in rheumatoid arthritis. J. Clin. Invest. 87:463-469.
32. Taub, D. D., and J. J. Oppenheim. 1994. Chemokines, inflammation and the immune system. Ther. Immunol. 1:229-246.
33. Unge, P., A. Gad, K. Eriksson, B. Bergman, L. Carling, P. Ekstrom, H. Glise, H. Gnarpe, O. Junghard, C. Lindholmer, B. Sandzen, L. Strandberg, A. Stubberod, and L. Weywadt. 1993. Amoxicillin added to omeprazole prevents relapse in the treatment of duodenal ulcer patients. Eur. J. Gastroenterol. Hepatol. 5:325-331.
34. Valle, J., K. Seppala, P. Sipponen, and T. Kosunen. 1991. Disappearance of gastritis after eradication of Helicobacter pylori. A morphometric study. Scand. J. Gastroenterol. 26:1057-1065.
35. van der Hulst, R. W., E. A. Rauws, B. Koycu, J. J. Keller, F. J. ten Kate, J. Dankert, G. N. Tytgat, and A. van der Ende. 1997. Helicobacter pylori reinfection is virtually absent after successful eradication. J. Infect. Dis. 176:196-200.
36. Walsh, J. H., and W. L. Peterson. 1995. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N. Engl. J. Med. 333: 984-991.
37. Vamaoka, Y., M. Kita, T. Kodama, N. Sawai, and J. Imanishi. 1996. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 110:1744-1752.